About this episode

Amy Cassalia discusses the complexities of life sciences transactions during the post-closing period.

McGuireWoods partner and host Geoff Cockrell invites colleague Amy Cassalia — whose practice is heavily weighted on life sciences transactions — to share insights about the post-closing period of these complex deals. The wide-ranging conversation covers the dynamics of “contingent consideration,” investor risk and buyers’ leverage. Amy explains why she sees high-level use of contingent payments in life sciences deals and why the term “commercially reasonable” often becomes critical when a deal spirals into litigation. Stay tuned as she unpacks leading trends. Top among them? The increasing use of earn-outs. Connect and Learn More ☑️ Amy Cassalia | LinkedIn ☑️ Geoff Cockrell | LinkedIn ☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X ☑️ Subscribe Apple Podcasts | Spotify | Amazon Music This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the…

People in this episode

Host: Geoff Cockrell

Guest: Amy Cassalia

Topics covered

• life sciences
• post-closing transactions
• contingent consideration
• investor risk
• buyers' leverage
• earn-outs
• litigation

Keywords

• life sciences
• contingent consideration
• investor risk
• buyers' leverage
• earn-outs
• commercially reasonable
• litigation

Mentioned in this episode

Organizations: McGuireWoods

More episodes of The Corner Series

• Episode 135: The Thaw Has Arrived in Provider Services M&A, With J. Kyle Brown · July 15, 2026 · 20 min
• Episode 134: Healthcare Compliance as a Deal Asset, With Wiks Moffat · July 8, 2026 · 15 min
• Episode 133: One Portal for Every Perinatal Journey, With Ian Gardner · June 17, 2026 · 20 min
• Episode 131: GP-Led Secondaries in Lower Middle Market, With Chris Lawrence · May 20, 2026 · 24 min
• Episode 130: Oncology and Retina: Follow the Drug Spend, With Jeanne Proia · May 6, 2026 · 21 min
• Episode 129 Special Crossover Edition: McGuireWoods Healthcare PE Conference Preview · April 23, 2026 · 22 min

Explore listener stats, chart rankings, contacts and more on the The Corner Series podcast page.